Oss-based Citryll, a biotech company pioneering therapies for immune-mediated inflammatory diseases, has closed an €85 million Series B funding round.
Copyright © 2023. Founders Today. All rights reserved
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?